Skip to main content
. 2018 Nov 8;11:717–728. doi: 10.2147/DMSO.S179153

Table 1.

Characteristics of the study population according to different levels of depression

Depression levels
Nondepressed Borderline clinical depression Moderate depression Severe depression Extreme depression P-valuea

Place of residence

Beirut 156 (50.2%) 24 (66.7%) 43 (72.9%) 17 (68%) 4 (80%) 0.007
South 99 (31.8%) 5 (13.9%) 4 (6.8%) 1 (4%) 0
North 20 (6.4%) 1 (2.8%) 5 (8.5%) 2 (8%) 1 (20%)
Beqaa 5 (1.6%) 1 (2.8%) 1 (1.7%) 1 (4%) 0
Mount Lebanon 31 (10%) 5 (13.9%) 6 (10.2%) 4 (16%) 0

Gender

Male 106 (34.1%) 15 (41.7%) 25 (42.4%) 8 (32%) 2 (40%) 0.691
Female 205 (65.9%) 21 (58.3%) 34 (57.6%) 17 (68%) 3 (60%)

Nationality

Lebanese 211 (67.8%) 27 (75%) 48 (81.4%) 14 (56%) 3 (60%) 0.126
Syrian 40 (12.9%) 4 (11.1%) 6 (10.2%) 8 (32%) 2 (40%)
Palestinian 59 (19%) 4 (11.1%) 5 (8.5%) 3 (12%) 0
Others 1 (0.3%) 1 (2.8%) 0 0 0

Occupation

Employed 80 (25.7%) 5 (13.9%) 11 (18.6%) 5 (20%) 0 0.037
Unemployed 176 (56.6%) 21 (58.3%) 31 (52.5%) 9 (36%) 2 (40%)
Student 4 (1.3%) 1 (2.8%) 0 1 (4%) 0
Retired 51 (16.4%) 9 (25%) 18 (28.8%) 10 (40%) 3 (60%)

Monthly income (in Lebanon $)

<300$ 140 (45%) 18 (50%) 36 (61%) 19 (76%) 5 (100%) 0.157
300–600$ 89 (28.6%) 11 (30.6%) 16 (27.1%) 4 (16%) 0
601–1,000$ 47 (15.1%) 7 (19.4%) 5 (8.5%) 2 (8%) 0
1,001–1,500$ 22 (7.1%) 0 1 (1.7%) 0 0
1,501–2,500$ 6 (1.9%) 0 1 (1.7%) 0 0
>2,500$ 7 (2.3%) 0 0 0 0

Diabetes duration

<1 year 31 (10%) 2 (5.6%) 2 (3.4%) 3 (12%) 0 0.447
1–5 years 89 (28.6%) 5 (13.9%) 16 (27.1%) 5 (20%) 1 (20%)
6–10 years 54 (17.4%) 9 (25%) 16 (27.1%) 5 (20%) 2 (40%)
>10 years 137 (44.1%) 20 (55.6%) 25 (42.4%) 12 (48%) 2 (40%)

Sleeping hours

<6 hours 87 (28%) 16 (44.4%) 22 (37.3%) 11 (44%) 1 (20%) 0.033
6–7 hours 144 (46.3%) 9 (25%) 24 (40.7%) 8 (32%) 1 (20%)
7–9 hours 72 (23.2%) 10 (27.8%) 12 (20.3%) 3 (12%) 3 (60%)
>9 hours 8 (2.6%) 1 (2.8%) 1 (1.7%) 3 (12%) 0

Patient relief

Yes 266 (85.5%) 30 (83.3%) 39 (66.1%) 23 (92%) 3 (60%) 0.002
No 45 (14.5%) 6 (16.7%) 20 (33.9%) 2 (8%) 2 (40%)

Social performance impairment

Yes 75 (24.1%) 14 (38.9%) 30 (50.8%) 13 (52%) 2 (40%) 0.00
No 236 (75.9%) 22 (61.1%) 29 (49.2%) 12 (48%) 3 (60%)

Disease perception

Terrified 48 (15.4%) 8 (22.2%) 19 (32.2%) 10 (40%) 3 (60%)
Okay with it 180 (57.9%) 22 (61.1%) 36 (61%) 10 (40%) 1 (20%) 0.00
Will never be cured 10 (3.2%) 3 (8.3%) 0 3 (12%) 1 (20%)
Neutral 72 (23.2%) 3 (8.3%) 3 (5.1%) 2 (8%) 0
Other 1 (0.3%) 0 1 (1.7%) 0 0

Notes:

a

Comparative studies were performed using the chi-squared test.